SCIENCE IN THE NEWS DAILY
Study Suggests Drug Can Cut Risk of Cancer's Return
from the Baltimore Sun
CHICAGO (Associated Press) - A drug to prevent bone loss during breast cancer treatment also substantially cut the risk that the cancer would return, results that left doctors excited about a possible new way to fight the disease.
It is the first large study to affirm wider anti-cancer hopes for Zometa and other bone-building drugs called bisphosphonates. Zometa, made by Novartis AG, is used now for cancers that have already spread to the bone.
The new study involved 1,800 premenopausal women taking hormone treatments for early-stage breast cancer. Zometa cut by one-third the chances that cancer would recur—in their bones or anywhere else.
Read more ...
Connect With Us:
PODCASTS: Expanding With the Cosmos
Using the Atacama Cosmology Telescope (ATC), a 6.5-meter microwave collector in Chile, cosmologists are piecing together the early history of the known universe. In an exclusive American Scientist interview, Arthur Kosowsky—a member of the ATC team and a professor in the Department of Physics and Astronomy at the University of Pittsburgh—discusses how he is using ATC to reach back in time billions of years to search for gravitational waves that could verify inflation and reveal unprecedented details about how the cosmos was born.
To view all multimedia content, click "Latest Multimedia."
Receive notification when new content is posted from the entire website, or choose from the customized feeds available.